Improvement in Left Ventricular Function of the Resected Myocardium after Septal Myectomy in Patients with Aortic Valve Replacement
DOI:
https://doi.org/10.59958/hsf.7275Keywords:
aortic valve stenosis, left ventricular outflow tract obstruction, strain, myocardial fibrosisAbstract
Background: Some surgeons have previously advocated for a more aggressive concomitant septal myectomy to address left ventricular outflow tract obstruction; however, concerns about the surgical complications of post-septal myectomy remain. Here, we aimed to assess the clinical, echocardiographic, and pathological findings following concomitant septal myectomy with surgical aortic valve replacement. Methods: We reviewed 21 patients who underwent surgical aortic valve replacement and concomitant septal myectomy from April 2014 to September 2019. The global and regional left ventricular ejection fraction changes between the perioperative periods were analyzed using two-dimensional speckle-tracking echocardiography. The resected myocardium was pathologically assessed. Results: No operative mortality was observed during the study period. Transthoracic echocardiography showed no significant differences in preoperative and postoperative left ventricular ejection fraction (68.1 ± 9.9% vs. 68.6 ± 6.0%, p = 0.82) or interventricular septum thickness (11.9 ± 1.4 mm vs. 11.5 ± 1.5 mm, p = 0.23). Interventricular septum thickness at the end-systolic phase, which is the maximum septal wall thickness, was significantly reduced postoperatively (27.7 ± 9.3 mm vs. 22.6 ± 5.5 mm, p < 0.05). The basal, mid, and apical septal areas improved with septal myectomy by 80%, 230%, and 27%, respectively, compared to perioperative echocardiography (basal septal, 80 ± 23%; mid septal, 230 ± 830%; apical septal, 27 ± 350%). Pathological examination of the resected myocardium revealed marked endocardial thickness (mean, 914 µm) with focal fibrosis. Conclusions: In aortic valve stenosis patients with septal hypertrophy, concomitant septal myectomy with surgical aortic valve replacement improved regional myocardial function and eliminated left ventricular outflow tract obstruction by removing thickened endocardium and prominent fibrosis.
References
Kayalar N, Schaff HV, Daly RC, Dearani JA, Park SJ. Concomitant septal myectomy at the time of aortic valve replacement for severe aortic stenosis. The Annals of Thoracic Surgery. 2010; 89: 459–464.
Makhija N, Magoon R, Balakrishnan I, Das S, Malik V, Gharde P. Left ventricular outflow tract obstruction following aortic valve replacement: A review of risk factors, mechanism, and management. Annals of Cardiac Anaesthesia. 2019; 22: 1–5.
Aurigemma G, Battista S, Orsinelli D, Sweeney A, Pape L, Cuénoud H. Abnormal left ventricular intracavitary flow acceleration in patients undergoing aortic valve replacement for aortic stenosis. A marker for high postoperative morbidity and mortality. Circulation. 1992; 86: 926–936.
Bartunek J, Sys SU, Rodrigues AC, van Schuerbeeck E, Mortier L, de Bruyne B. Abnormal systolic intraventricular flow velocities after valve replacement for aortic stenosis. Mechanisms, predictive factors, and prognostic significance. Circulation. 1996; 93: 712–719.
Turina J, Jenni R, Krayenbuehl HP, Turina M, Rothlin M. Echocardiographic findings late after myectomy in hypertrophic obstructive cardiomyopathy. European Heart Journal. 1986; 7: 685–692.
Panza JA, Maron BJ. Valvular aortic stenosis and asymmetric septal hypertrophy: diagnostic considerations and clinical and therapeutic implications. European Heart Journal. 1988; 9: 71–76.
Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, et al. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020; 142: e558–e631.
Mitchell C, Rahko PS, Blauwet LA, Canaday B, Finstuen JA, Foster MC, et al. Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography. Journal of the American Society of Echocardiography: Official Publication of the American Society of Echocardiography. 2019; 32: 1–64.
Nakamura T, Iwanaga Y, Yasuda M, Kawamura T, Miyaji Y, Morooka H, et al. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis. The International Journal of Cardiovascular Imaging. 2016; 32: 613–620.
Burke MA, Cook SA, Seidman JG, Seidman CE. Clinical and Mechanistic Insights Into the Genetics of Cardiomyopathy. Journal of the American College of Cardiology. 2016; 68: 2871–2886.
Khan SA, Dong H, Joyce J, Sasaki T, Chu ML, Tsuda T. Fibulin-2 is essential for angiotensin II-induced myocardial fibrosis mediated by transforming growth factor (TGF)-β. Laboratory Investigation; a Journal of Technical Methods and Pathology. 2016; 96: 773–783.
Goor D, Lillehei CW, Edwards JE. The ``sigmoid septum''. Variation in the contour of the left ventricular outt. The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine. 1969; 107: 366–376.
Efthimiadis GK, Pagourelias ED, Parcharidou D, Gossios T, Kamperidis V, Theofilogiannakos EK, et al. Clinical characteristics and natural history of hypertrophic cardiomyopathy with midventricular obstruction. Circulation Journal: Official Journal of the Japanese Circulation Society. 2013; 77: 2366–2374.
Leitman M, Lysyansky P, Sidenko S, Shir V, Peleg E, Binenbaum M, et al. Two-dimensional strain-a novel software for real-time quantitative echocardiographic assessment of myocardial function. Journal of the American Society of Echocardiography: Official Publication of the American Society of Echocardiography. 2004; 17: 1021–1029.
Zito C, Longobardo L, Citro R, Galderisi M, Oreto L, Carerj ML, et al. Ten Years of 2D Longitudinal Strain for Early Myocardial Dysfunction Detection: A Clinical Overview. BioMed Research International. 2018; 2018: 8979407.
Di Tommaso L, Stassano P, Mannacio V, Russolillo V, Monaco M, Pinna G, et al. Asymmetric septal hypertrophy in patients with severe aortic stenosis: the usefulness of associated septal myectomy. The Journal of Thoracic and Cardiovascular Surgery. 2013; 145: 171–175.
Kitaoka H, Tsutsui H, Kubo T, Ide T, Chikamori T, Fukuda K, et al. JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies. Circulation Journal: Official Journal of the Japanese Circulation Society. 2021; 85: 1590–1689.
Maron BJ, Henry WL, Roberts WC, Epstein SE. Comparison of echocardiographic and necropsy measurements of ventricular wall thicknesses in patients with and without disproportionate septal thickening. Circulation. 1977; 55: 341–346.
Arbustini E, Gavazzi A, Pozzi R, Pucci A, Grasso M, Diegoli M, et al. Endomyocardial biopsy of normal donor hearts before cardiac transplantation. A morphological and morphometrical study in 97 cases. The American Journal of Cardiovascular Pathology. 1992; 4: 1–8.
Morito N, Morie S. Significance of Endocardial Pathology in Endomyocardial Biopsy Specimens of Various Heart Diseases. Shinshu Medical Journal. 1999; 47: 59–67.
Giordano C, Francone M, Cundari G, Pisano A, d'Amati G. Myocardial fibrosis: morphologic patterns and role of imaging in diagnosis and prognostication. Cardiovascular Pathology: the Official Journal of the Society for Cardiovascular Pathology. 2022; 56: 107391.
Gupta S, Ge Y, Singh A, Gräni C, Kwong RY. Multimodality Imaging Assessment of Myocardial Fibrosis. JACC. Cardiovascular Imaging. 2021; 14: 2457–2469.
